Jpmorgan Chase & Co »

In8bio shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of In8bio (INAB) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in In8bio

Tip: Access up to 7 years of quarterly data

All positions including In8bio held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in In8bio by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $47 34 1.38
2023-09-30 $19 18 1.06

More positions owned by Jpmorgan Chase & Co

Microsoft Corp Common (MSFT)
Apple Common (AAPL)
Amazon Common (AMZN)
Spdr S&p 500 Etf Trust Fund (SPY)
Nvidia Corporation Common (NVDA)
Meta Platforms Common (META)
Unitedhealth Group Common (UNH)
Vanguard Total Intl Bond Etf Fund (BNDX)
Alphabet Common (GOOG)
Eli Lilly & Co Common (LLY)
Mastercard Incorporated Common (MA)
Alphabet Common (GOOGL)
Abbvie Common (ABBV)
Vanguard Total Bond Market Fund (BND)
Tesla Common (TSLA)

View all positions for Jpmorgan Chase & Co

Top funds holding In8bio

AIGH Capital Management
Alyeska Investment Group
683 Capital Management
Vanguard Group
Voss Capital
Stonegate Investment Group
Sigma Planning
Texas Capital Bank Wealth Management Services
Two Sigma Investments
Overbrook Management Corp.
Citadel Advisors
Wela Strategies
Charles Schwab Investment Management
Westside Investment Management
HighTower Advisors

View all funds holding In8bio